Ultralife (NASDAQ:ULBI) Raised to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Ultralife (NASDAQ:ULBIFree Report) from a buy rating to a strong-buy rating in a research note released on Wednesday.

Separately, Benchmark raised their target price on shares of Ultralife from $12.00 to $13.00 and gave the company a buy rating in a research report on Tuesday, March 5th.

Read Our Latest Stock Analysis on Ultralife

Ultralife Stock Performance

NASDAQ ULBI opened at $11.39 on Wednesday. The company has a current ratio of 3.80, a quick ratio of 2.02 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $187.37 million, a price-to-earnings ratio of 25.89 and a beta of 1.26. The firm’s 50 day simple moving average is $9.16 and its 200 day simple moving average is $8.20. Ultralife has a 1 year low of $3.92 and a 1 year high of $11.85.

Ultralife (NASDAQ:ULBIGet Free Report) last posted its quarterly earnings results on Thursday, February 15th. The technology company reported $0.18 earnings per share (EPS) for the quarter. The business had revenue of $44.55 million for the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%.

Institutional Trading of Ultralife

Hedge funds have recently added to or reduced their stakes in the stock. LSV Asset Management lifted its holdings in shares of Ultralife by 32.0% during the third quarter. LSV Asset Management now owns 16,900 shares of the technology company’s stock worth $165,000 after purchasing an additional 4,100 shares during the period. Jump Financial LLC acquired a new position in shares of Ultralife during the third quarter worth $118,000. Barclays PLC acquired a new position in shares of Ultralife during the third quarter worth $127,000. ClariVest Asset Management LLC acquired a new position in shares of Ultralife during the third quarter worth $616,000. Finally, Acadian Asset Management LLC acquired a new position in shares of Ultralife during the third quarter worth $1,039,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

See Also

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.